Found: 1387
Select item for more details and to access through your institution.
Circadian disruption promotes the neurotoxicity of oligomeric alpha-synuclein in mice.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00798-9
- By:
- Publication type:
- Article
Polymeric Nanozyme with SOD Activity Capable of Inhibiting Self‐ and Metal‐Induced α‐Synuclein Aggregation.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 37, p. 1, doi. 10.1002/chem.202401331
- By:
- Publication type:
- Article
Insight into the Effect of Methylglyoxal on the Conformation, Function, and Aggregation Propensity of α‐Synuclein.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 36, p. 1, doi. 10.1002/chem.202400890
- By:
- Publication type:
- Article
Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 23, p. 1, doi. 10.1002/chem.202303921
- By:
- Publication type:
- Article
Probing Peptidylprolyl Bond cis/trans Status Using Distal <sup>19</sup>F NMR Reporters.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 16, p. 1, doi. 10.1002/chem.202203017
- By:
- Publication type:
- Article
Yeast red pigment, protein aggregates, and amyloidoses: a review.
- Published in:
- Cell & Tissue Research, 2022, v. 388, n. 2, p. 211, doi. 10.1007/s00441-022-03609-w
- By:
- Publication type:
- Article
AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease.
- Published in:
- Cell & Tissue Research, 2019, v. 378, n. 1, p. 1, doi. 10.1007/s00441-019-03013-x
- By:
- Publication type:
- Article
The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 313, doi. 10.1007/s00441-018-2856-4
- By:
- Publication type:
- Article
Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 149, doi. 10.1007/s00441-018-2854-6
- By:
- Publication type:
- Article
The concept of alpha-synuclein as a prion-like protein: ten years after.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 161, doi. 10.1007/s00441-018-2814-1
- By:
- Publication type:
- Article
Release and uptake of pathologic alpha-synuclein.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 175, doi. 10.1007/s00441-017-2775-9
- By:
- Publication type:
- Article
Genetic risk factors in Parkinson’s disease.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 9, doi. 10.1007/s00441-018-2817-y
- By:
- Publication type:
- Article
iPS cells in the study of PD molecular pathogenesis.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 61, doi. 10.1007/s00441-017-2749-y
- By:
- Publication type:
- Article
Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
- Published in:
- Cell & Tissue Research, 2018, v. 373, n. 1, p. 233, doi. 10.1007/s00441-017-2733-6
- By:
- Publication type:
- Article
Mepirapim, a novel synthetic cannabinoid, induces Parkinson's disease-related behaviors by causing maladaptation of the dopamine system in the brain.
- Published in:
- Archives of Toxicology, 2023, v. 97, n. 2, p. 581, doi. 10.1007/s00204-022-03414-y
- By:
- Publication type:
- Article
Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.
- Published in:
- Archives of Toxicology, 2017, v. 91, n. 3, p. 1245, doi. 10.1007/s00204-016-1788-6
- By:
- Publication type:
- Article
Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.
- Published in:
- GeroScience, 2022, v. 44, n. 3, p. 1551, doi. 10.1007/s11357-022-00576-6
- By:
- Publication type:
- Article
Elevated α-synuclein levels inhibit mitophagic flux.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00696-0
- By:
- Publication type:
- Article
A topographical atlas of α-synuclein dosage and cell type-specific expression in adult mouse brain and peripheral organs.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00672-8
- By:
- Publication type:
- Article
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00662-w
- By:
- Publication type:
- Article
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00650-0
- By:
- Publication type:
- Article
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00627-5
- By:
- Publication type:
- Article
A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00632-2
- By:
- Publication type:
- Article
Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00614-w
- By:
- Publication type:
- Article
Linking acetylated α-Tubulin redistribution to α-Synuclein pathology in brain of Parkinson's disease patients.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00607-9
- By:
- Publication type:
- Article
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00618-6
- By:
- Publication type:
- Article
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00606-w
- By:
- Publication type:
- Article
Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00604-y
- By:
- Publication type:
- Article
USP19 deubiquitinase inactivation regulates α-synuclein ubiquitination and inhibits accumulation of Lewy body-like aggregates in mice.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00601-1
- By:
- Publication type:
- Article
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00584-z
- By:
- Publication type:
- Article
Extracellular high molecular weight α-synuclein oligomers induce cell death by disrupting the plasma membrane.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00583-0
- By:
- Publication type:
- Article
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00574-1
- By:
- Publication type:
- Article
α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00570-5
- By:
- Publication type:
- Article
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00552-7
- By:
- Publication type:
- Article
AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00542-9
- By:
- Publication type:
- Article
Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00519-8
- By:
- Publication type:
- Article
Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00510-3
- By:
- Publication type:
- Article
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00517-w
- By:
- Publication type:
- Article
Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00502-3
- By:
- Publication type:
- Article
MAPKAPK2, a potential dynamic network biomarker of α-synuclein prior to its aggregation in PD patients.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00479-z
- By:
- Publication type:
- Article
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00484-2
- By:
- Publication type:
- Article
Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00491-3
- By:
- Publication type:
- Article
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00476-2
- By:
- Publication type:
- Article
A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00473-5
- By:
- Publication type:
- Article
Patients with isolated REM-sleep behavior disorder have elevated levels of alpha-synuclein aggregates in stool.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00458-4
- By:
- Publication type:
- Article
C/EBPβ/AEP is age-dependently activated in Parkinson's disease and mediates α-synuclein in the gut and brain.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-022-00430-8
- By:
- Publication type:
- Article
Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00444-w
- By:
- Publication type:
- Article
Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00437-1
- By:
- Publication type:
- Article
Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00434-4
- By:
- Publication type:
- Article
Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00388-7
- By:
- Publication type:
- Article